Total Funding
87
67
Total FundingDebt Financing raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
57165
Endolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections.
- Jason Holder: Co-Founder and Chief Science Officer
About the Company
Endolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections. Its therapeutics kill pathogenic bacteria, including multidrug-resistant bacteria, and help the healthcare industry address the most resistant antibiotic infections that are difficult to access and treat.
